Cover Image
市場調查報告書

心臟再同步化治療的心臟去顫器的全球市場:2016∼2020年

Global Cardiac Resynchronization Therapy Defibrillator Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361414
出版日期 內容資訊 英文 56 Pages
訂單完成後即時交付
價格
Back to Top
心臟再同步化治療的心臟去顫器的全球市場:2016∼2020年 Global Cardiac Resynchronization Therapy Defibrillator Market 2016-2020
出版日期: 2016年06月07日 內容資訊: 英文 56 Pages
簡介

心房纖維顫動的高風險患者,為了抑制心律不整伴隨的風險到最小限度而採用心臟再同步化治療用心臟去顫器。透過使用心臟再同步化治療的心臟去顫器,促進心臟的電氣活動功能,改善心率。全球心臟再同步化治療的心臟去顫器市場,預計2016∼2020年,以年複合成長率8.36%擴大。

本報告提供全球心臟再同步化治療的心臟去顫器市場現狀與2020年預測,市場規模與銷售趨勢,主要供應商的競爭環境與簡介彙整。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 心臟再同步化治療用心臟去顫器植入費用

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第8章 推動市場的要素

  • 心臟疾病的發病率上升
  • 法律規章認證的擴大
  • 臨床上的關懷
  • 民眾的意識提升

第9章 促進要素的影響

第10章 市場課題

  • 成本的高度
  • 替代設備受歡迎
  • 併發症

第11章 促進要素與課題的影響

第12章 市場趨勢

  • 臨床應用的MRI的使用擴大
  • 著重研究開發
  • 機器人支援手術廣受歡迎

第13章 供應商環境

  • 競爭模式
  • 市場佔有率分析
  • 主要供應商分析
  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical
  • 其他值得注意的供應商

第14章 附錄

第15章 關於Technavio

目錄
Product Code: IRTNTR9455

About the Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market

Heart failure, a condition when the heart cannot pump enough blood to meet the body's need, is one of the leading causes of death. Heart failure and stroke, if occurred together, can lead to major health problems or cause sudden death.

Irregularity in ventricular rate can lead to reduction of diastolic dysfunction, a condition when there is abnormality in how the heart fills with blood causing pressure in the pulmonary vessel, leading to AF. Hence, patients with high risk of AF use CRT-D devices to minimize the risk associated with irregular heartbeat. The use of CRT-D devices enhances the functioning of the heart's electrical activity and improves heart rhythm. These devices are small in size and are placed below the collar bone.

Technavio's analysts forecast the global cardiac resynchronization therapy defibrillator (CRT-D) market to grow at a CAGR of 8.36% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy defibrillator (CRT-D) market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of CRT-D devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • LivaNova

Other Prominent Vendors

  • BIOTRONIK
  • Cook Medical
  • Spectranetics

Market driver

  • Clinical considerations
  • For a full, detailed list, view our report

Market challenge

  • High cost
  • For a full, detailed list, view our report

Market trend

  • Growing popularity of robotic-assistance surgery
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Cost analysis of CRT-D device implantation

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Geographical segmentation

  • CRT-D market in Americas
  • CRT-D market in EMEA
  • CRT-D market in APAC

PART 08: Market drivers

  • Increased incidence of cardiac disorders
  • Increasing regulatory approvals
  • Clinical considerations
  • Increased public awareness

PART 09: Impact of drivers

PART 10: Market challenges

  • High cost
  • Popularity of alternative devices
  • Complications associated with CRT-D devices

PART 11: Impact of drivers and challenges

PART 12: Market trends

  • Increased use of MRI in clinical applications
  • Focus on R&D
  • Growing popularity of robotic-assistance surgery

PART 13: Vendor landscape

  • Competitive scenario
  • Market share analysis
  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

PART 15: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Cost comparison of CRT-D and ICD system implantation
  • Exhibit 03: Cost difference of system implantation and medical services in CRT-D 2015
  • Exhibit 04: Cost difference of system implantation and medical services in ICD 2015
  • Exhibit 05: Cost breakdown of system components in CRT-D implantation 2015
  • Exhibit 06: Cost breakdown of system components in ICD implantation 2015
  • Exhibit 07: Cost breakdown of medical services in CRT-D implantation 2015
  • Exhibit 08: Cost breakdown of medical services in ICD implantation 2015
  • Exhibit 09: Global CRT-D market 2015-2020 ($ billions)
  • Exhibit 10: Five forces analysis
  • Exhibit 11: Global CRT-D market by geography 2015
  • Exhibit 12: Global CRT-D market by geography 2020
  • Exhibit 13: Global CRT-D market by geography 2015-2020 ($ millions)
  • Exhibit 14: Global CRT-D market by geography 2015-2020 (%)
  • Exhibit 15: CRT-D market in Americas 2015-2020 ($ billions)
  • Exhibit 16: Prevalence of AF in few European countries 2014 (%)
  • Exhibit 17: CRT-D market in EMEA 2015-2020 ($ millions)
  • Exhibit 18: CRT-D market in APAC 2015-2020 ($ millions)
  • Exhibit 19: Impact of drivers
  • Exhibit 20: Impact of drivers and challenges
  • Exhibit 21: Top vendors in global CRT-D market 2015
  • Exhibit 22: Boston Scientific: Cardiac rhythm management segmentation by revenue 2014
  • Exhibit 23: Boston Scientific: Cardiac rhythm management segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 24: Boston Scientific: Cardiac rhythm management geographical segmentation by revenue 2014
  • Exhibit 25: Boston Scientific: Key takeaways
  • Exhibit 26: LivaNova: Cardiac rhythm management segmentation by revenue 2014
  • Exhibit 27: LivaNova: Cardiac rhythm management segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 28: LivaNova: Key takeaways
  • Exhibit 29: Medtronic: Key takeaways
  • Exhibit 30: St. Jude Medical: Key takeaways
Back to Top